Nurix Receives $2,075,000 New Financing Round

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    1700 Owens Street San Francisco, CA 94158
  • Company Description
    The company is focused on the discovery and development of small molecule inhibitors of ubiquitin ligases to treat a broad range of proliferative and degenerative diseases.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    Proceeds purposes are to be used for working capital. SEC regulatory filing. Contact technology company for solicitation details, if applicable.
  • M&A Terms
  • Venture Investor